Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI)

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 729-731

  Zhitkovich, Anatoly ^a   Quievryn, George ^a   Messer, Joseph ^a   Motylevich, Zhanna ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Biomarker; Chromium; Cysteine; DNA adduct; Mutagenesis

Indexed keywords

BIOCHEMICAL MARKER; BUFFER; CHROMIUM; CYSTEINE; DNA; SUGAR PHOSPHATE;

ARTICLE; CARCINOGENICITY; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA REPLICATION; DNA STRUCTURE; EXPOSURE; FIBROBLAST; GENOTOXICITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; METAL METABOLISM; MUTAGENICITY; OXIDATION; PLASMID; PRIORITY JOURNAL;

EID: 0036801386     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5729     Document Type: Article

References (23)

1. IARC. Chromium, Nickel and Welding. IARC Monogr Eval Carcinog Risk Hum 48:49-256(1990).
2. Sorahan T, Burges DC, Hamilton L, Harrington JM. Lung cancer mortality in nickel/chromium platers, 1946-1995. Occup Environ Med 55;236-242 (1998).
3. Snow E. Metal carcinogenesis: mechanistic implications. Pharmacol Ther 53:31-65 (1992).
4. Landolph JR. Role of free radicals in metal-induced carcinogenesis. In: Metal Ions in Biological Systems (Sigel A, Sigel H, eds). New York:Marcel Dekker, 1999;445-483.
5. Suzuki Y, Fukuda K. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch Toxicol 64:169-176 (1990).
6. Standeven AM, Wetterhahn KE. Ascorbate is the principal reductant of chromium (VI) in rat lung ultrafiltrates and cystosols, and mediates chromium-DNA binding. Carcinogenesis 13:1319-1324 (1992).
7. Yuann JM, Liu KJ, Hamilton JW, Wetterhahn KE. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2′-deoxyguanosine in liver and kidney of Osteogenic Disorder Shionogi rats following treatment with chromium(VI). Carcinogenesis 20:1267-1275 (1999).
8. Kitagawa S, Seki H, Kametani F, Sakurai H. EPR study on the interaction of hexavalent chromium with glutathione or cysteine: production of pentavalent chromium and its stability. Inorg Chim Acta 152:251-255 (1988).
9. Stearns DM, Wetterhahn KE. Reaction of Cr(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. Chem Res Toxicol 7:219-230 (1994).
10. Shi X, Dong Z, Dall NS, Gannett PM. Chromate-mediated free radical generation from cysteine, penicillamine, hydrogen peroxide, and lipid peroxides. Biochem Biophys Acta 1226:65-72 (1994).
11. Lay P, Levina A. Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: implications for chromium-induced genotoxicities. J Am Chem Soc 120:6704-6714 (1998).
12. Zhang L, Lay P, EPR spectroscopic studies of the reactions of Cr(VI) with L-ascorbic, L-dehydroascorbic acid, and 5, 6-0-isopropylidene-L-ascorbic acid in water. Implications for chromium(VI) genotoxicity. J Am Chem Soc 118:12624-12637 (1996).
13. Sugden KD, Stearns DM. The role of chromium(V) in the mechanism of chromate-induced ocidative DNA damage and cancer. J Environ Pathol Oncol 19:215-230 (2000).
14. Lafleur MV, Retel J. Contrasting effects of SH-compounds on oxidative DNA damage: repair and increase of damage. Mutat Res 295:1-10 (1993).
15. Zhitkovich A, Voitkun V, Costa M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 16:907-913 (1995).
16. Bridgewater LC, Manning FCR, Patierno SR. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking. Carcinogenesis 15:2421-2427 (1994).
17. Voitkun V, Zhitkovich A, Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucl Acids Res 26:2024-2030 (1998).
18. Zhitkovich A, Messer J, Shrager S. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr-DNA adducts in the absence of oxidative DNA damage. Chem Res Toxicol 13:1114-1124 (2000).
19. Zhitkovich A, Song Y, Quievryn G, Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: the role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40:549-560 (2001).
20. Quievryn G, Goulart M, Messer G, Zhitkovich A. Reduction of Cr(VI) by cysteine:significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Mol Cell Biochem 222:107-118 (2001).
21. Kwong DWJ, Pennington DE. Stoichiometry, kinetics, and mechanisms of the chromium(VI) oxidation of L-cysteine. Inorg Chem 23:2538-2532 (1984).
22. O'Brien T, Xu J, Patierno SR. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol Cell Biochem 222:173-182 (2001).
23. Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn E. Reaction of chromium (VI) with hydrogen peroxide in the pressence of glutathione: reactive intermediates and resulting DNA damage. Chem Res Toxicol 3:595-603 (1990).